Bank Mandiri (Persero) Crescita futura

Future criteri di controllo 3/6

Bank Mandiri (Persero) prevede che gli utili e i ricavi cresceranno rispettivamente di 9% e 12.1% all'anno. Si prevede che l'EPS crescerà di 8.4% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 21.1% in 3 anni.

Informazioni chiave

9.0%

Tasso di crescita degli utili

8.4%

Tasso di crescita dell'EPS

Banks crescita degli utili	10.7%
Tasso di crescita dei ricavi	12.1%
Rendimento futuro del capitale proprio	21.1%
Copertura analitica	Good
Ultimo aggiornamento	26 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

IDX:BMRI - Stime future degli analisti e dati finanziari passati (IDR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	178,951,447	69,980,672	N/A	N/A	15
12/31/2025	162,641,615	63,104,599	N/A	N/A	18
12/31/2024	146,984,375	56,763,323	N/A	N/A	16
9/30/2024	133,704,511	58,013,868	-247,192,818	-240,457,903	N/A
6/30/2024	131,621,491	56,378,810	-217,594,707	-211,952,550	N/A
3/31/2024	128,598,922	55,202,064	-181,215,954	-175,753,838	N/A
12/31/2023	127,454,571	55,060,057	-160,586,383	-155,565,347	N/A
9/30/2023	121,698,513	49,581,394	-122,962,368	-118,492,049	N/A
6/30/2023	116,231,734	46,193,314	-120,233,192	-115,218,429	N/A
3/31/2023	113,260,546	43,699,281	-91,161,724	-86,465,368	N/A
12/31/2022	109,397,530	41,170,637	-107,337,350	-102,237,704	N/A
9/30/2022	102,443,935	39,451,866	-94,063,860	-89,157,274	N/A
6/30/2022	96,806,573	35,736,231	-44,302,184	-40,357,034	N/A
3/31/2022	91,678,472	32,141,309	-15,312,962	-11,137,464	N/A
12/31/2021	86,552,332	28,028,155	-21,425,351	-17,788,756	N/A
9/30/2021	84,846,745	22,000,577	-12,368,369	-8,322,534	N/A
6/30/2021	77,853,475	19,007,810	-78,339,869	-74,088,512	N/A
3/31/2021	69,788,729	14,802,019	-53,140,650	-49,008,273	N/A
12/31/2020	70,268,800	16,799,515	-21,798,738	-17,362,742	N/A
9/30/2020	69,558,773	21,260,138	-72,083,186	-67,484,768	N/A
6/30/2020	74,126,227	24,244,355	-17,388,822	-12,887,415	N/A
3/31/2020	79,171,686	28,164,908	-80,306,286	-75,610,912	N/A
12/31/2019	76,835,074	27,482,133	-78,246,587	-73,411,991	N/A
9/30/2019	76,027,346	27,173,159	-36,939,011	-33,242,436	N/A
6/30/2019	74,283,969	26,367,563	-54,750,281	-50,956,593	N/A
3/31/2019	73,705,983	26,388,234	-61,580,383	-57,840,590	N/A
12/31/2018	71,246,382	25,015,021	-61,031,952	-57,737,938	N/A
9/30/2018	67,586,337	23,662,323	-70,878,038	-67,640,360	N/A
6/30/2018	67,216,390	23,354,754	N/A	-61,983,351	N/A
3/31/2018	65,275,820	22,420,581	N/A	-34,609,807	N/A
12/31/2017	62,467,327	20,639,683	N/A	-47,717,816	N/A
9/30/2017	55,848,786	16,862,594	N/A	-50,356,492	N/A
6/30/2017	53,048,188	16,189,190	N/A	-52,609,707	N/A
3/31/2017	50,346,908	14,068,593	N/A	-37,382,619	N/A
12/31/2016	49,535,827	13,806,565	N/A	-43,796,675	N/A
9/30/2016	55,010,796	17,765,646	N/A	-35,953,738	N/A
6/30/2016	53,839,017	17,490,908	N/A	-17,260,879	N/A
3/31/2016	54,813,984	19,013,591	N/A	-36,902,726	N/A
12/31/2015	55,424,160	20,334,968	N/A	-24,111,371	N/A
9/30/2015	53,248,952	20,000,881	N/A	-30,706,227	N/A
6/30/2015	53,503,321	20,210,907	N/A	-62,902,058	N/A
3/31/2015	52,139,677	20,085,676	N/A	-56,106,318	N/A
12/31/2014	51,119,548	19,871,873	N/A	-62,440,155	N/A
9/30/2014	51,723,012	19,853,877	N/A	-49,873,307	N/A
6/30/2014	49,905,157	19,495,148	N/A	-40,083,737	N/A
3/31/2014	48,049,764	18,824,928	N/A	-56,596,916	N/A
12/31/2013	46,147,429	18,203,753	N/A	-58,091,206	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di BMRI ( 9% all'anno) è superiore al tasso di risparmio ( 6.8% ).

Guadagni vs Mercato: Si prevede che gli utili di BMRI ( 9% all'anno) cresceranno più lentamente rispetto al mercato ID ( 19.6% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di BMRI cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di BMRI ( 12.1% all'anno) crescerà più rapidamente del mercato ID ( 9.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di BMRI ( 12.1% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di BMRI sarà elevato tra 3 anni ( 21.1 %)

Bank Mandiri (Persero) Crescita futura

Future criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target increased by 7.3% to Rp6,402

Analysts update estimates

Recent updates

Third quarter 2024 earnings released: EPS: Rp166 (vs Rp98.80 in 3Q 2023)

President Director recently bought Rp1.1b worth of stock

Second quarter 2024 earnings: Revenues in line with analyst expectations

Vice President Director recently bought Rp1.0b worth of stock

Board Member recently bought Rp938m worth of stock

First quarter 2024 earnings released: EPS: Rp136 (vs Rp135 in 1Q 2023)

Now 23% overvalued after recent price rise

Dividend of Rp354 announced

Full year 2023 earnings released

Board Member recently bought Rp1.7m worth of stock

Board Member recently bought Rp878m worth of stock

Board Member recently bought Rp1.1b worth of stock

Board Member recently bought Rp1.5b worth of stock

Key Executive recently bought Rp1.1b worth of stock

President Director recently bought Rp580m worth of stock

Key Executive recently bought Rp1.3b worth of stock

Price target increased by 7.3% to Rp6,402

Second quarter 2023 earnings released: EPS: Rp272 (vs Rp109 in 2Q 2022)

First quarter 2023 earnings released: EPS: Rp135 (vs Rp108 in 1Q 2022)

Upcoming dividend of Rp529 per share at 3.6% yield

Full year 2022 earnings released

PT Bank Mandiri (Persero) Tbk to Report Q4, 2022 Results on Jan 31, 2023

No independent directors

Third quarter 2022 earnings released: EPS: Rp224 (vs Rp144 in 3Q 2021)

Second quarter 2022 earnings released: EPS: Rp218 (vs Rp141 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

No independent directors

Upcoming dividend of Rp361 per share

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Second quarter 2021 earnings released: EPS Rp141 (vs Rp51.01 in 2Q 2020)

New 90-day low: Rp6,250

Full year 2020 earnings released

New 90-day high: Rp6,950

New 90-day high: Rp6,800

New 90-day high: Rp6,375

Third quarter earnings released

New 90-day high - Rp6,250

Analysts update estimates

New 90-day high - Rp5,700

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita